MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with C

Cabozantinib

Cabozantinib 20mg capsules

No stability information

Stability notes for Cabozantinib 20mg capsules

There are no stability notes for this medicine.

Supplier

Cometriq 20mg capsules (Ipsen Ltd)

Cabozantinib 20mg capsules and Cabozantinib 80mg capsules

No stability information

Stability notes for Cabozantinib 20mg capsules and Cabozantinib 80mg capsules

There are no stability notes for this medicine.

Supplier

Cometriq 20mg capsules and Cometriq 80mg capsules (Ipsen Ltd)

Cabozantinib 20mg tablets

No stability information

Stability notes for Cabozantinib 20mg tablets

There are no stability notes for this medicine.

Suppliers

Cabozantinib 20mg tablets (A A H Pharmaceuticals Ltd)
Cabozantinib 20mg tablets (Ipsen Ltd)

Cabozantinib 40mg tablets

No stability information

Stability notes for Cabozantinib 40mg tablets

There are no stability notes for this medicine.

Suppliers

Cabozantinib 40mg tablets (A A H Pharmaceuticals Ltd)
Cabozantinib 40mg tablets (Ipsen Ltd)

Cabozantinib 60mg tablets

No stability information

Stability notes for Cabozantinib 60mg tablets

There are no stability notes for this medicine.

Suppliers

Cabozantinib 60mg tablets (A A H Pharmaceuticals Ltd)
Cabozantinib 60mg tablets (Ipsen Ltd)

Cabozantinib 80mg capsules

No stability information

Stability notes for Cabozantinib 80mg capsules

There are no stability notes for this medicine.

Supplier

Cometriq 80mg capsules (Ipsen Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.